VF
VBIO

Virtu Financial’s Valion Bio VBIO Stock Holding History

Virtu Financial’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Buy
+1,569
New +$34.1K ﹤0.01% 1351
2024
Q4 		– Sell
-49
Closed -$5K – 2049
2024
Q3 		$5K Sell
49
-50
-51% -$7.55K ﹤0.01% 1249
2024
Q2 		$16K Buy
+99
New +$31.2K ﹤0.01% 1061

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Virtu Financial's VBIO Position: Q2 2026 in Review

Virtu Financial opened a new position in Valion Bio (VBIO) in Q2 2026: 1,569 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #1351 among its holdings. This is a return to the name: Virtu Financial previously reported a position in VBIO as recently as Q3 2024.

Virtu Financial first reported a position in VBIO in Q2 2024 and has held it in 3 quarters since. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • Virtu Financial held 1,569 shares of Valion Bio worth $20K as of Q2 2026.
  • Valion Bio was a new Virtu Financial position in Q2 2026.
  • Valion Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1351 holding.
  • Virtu Financial first reported a position in Valion Bio in Q2 2024 and has held it in 3 quarters since.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.